Lubris

Showing 1 posts of 1 posts found.

novartis_outside_1

Novartis takes on dry-eye market with drug in-licensing move

April 7, 2017
Medical Communications, Sales and Marketing Lubris, Novartis, dry eye

Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …

The Gateway to Local Adoption Series

Latest content